CRMD vs MGM · P/E 3.9, rev $43.5M vs P/E 64, rev $4.45B
CorMedix Inc (CRMD) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the CRMD and MGM stock pages for the full models.
Not investment advice.